Literature DB >> 21659433

Patterns of retention of particulate matter in lung tissues of patients with COPD: potential role in disease progression.

Sean H Ling1, John E McDonough1, John V Gosselink1, W Mark Elliott1, Shizu Hayashi1, James C Hogg1, Stephan F van Eeden2.   

Abstract

BACKGROUND: Particulate matter (PM) is present in lung tissues of smokers and urban dwellers. This study was designed to quantify the burden of PM in different lung tissues of subjects with COPD and determine its relationship to disease severity.
METHODS: Surgical lung tissue samples from nonsmokers (control subjects) were compared with those from smokers with normal spirometry and subjects in the four other categories of the GOLD (Global Initiative for Obstructive Lung Disease) classification of COPD severity using quantitative histologic techniques.
RESULTS: PM was present in the lung parenchyma, blood vessel walls, airways, lymphoid follicles, and alveolar macrophages. The total burden of PM (volume fraction [Vv]) in all tissues of the lung was higher in smokers than nonsmokers (P < .001) and also in smokers with airflow obstruction compared with the smokers with normal spirometry (P < .01). There was an incremental increase in total PM burden with increased COPD severity that peaked in GOLD II and then trended downward in GOLD III and IV COPD. This same pattern of PM retention was also observed in alveolar walls. The total burden of PM in lung tissues correlated with a decline in FEV(1)/FVC as well as pack-years smoking. mRNA expression of fibrinogen (γ chain) correlated with total lung burden of PM and burden of PM in lung parenchyma (r(2) = 0.22, P < .001).
CONCLUSIONS: We conclude that retained PM is widely distributed in lung tissues of subjects with COPD and that cigarette smoke exposure and airflow obstruction are associated with retention of PM in lung tissues. We attribute the downward trend in PM burden in severe COPD to either less deposition and retention or selective removal of PM containing tissues by emphysematous destruction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659433     DOI: 10.1378/chest.10-2281

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Anthocyanins from Eugenia brasiliensis edible fruits as potential therapeutics for COPD treatment.

Authors:  Gema Flores; Keyvan Dastmalchi; Sturlainny Paulino; Kathleen Whalen; Abdoulaye J Dabo; Kurt A Reynertson; Robert F Foronjy; Jeanine M D'Armiento; Edward J Kennelly
Journal:  Food Chem       Date:  2012-02-18       Impact factor: 7.514

3.  An investigation of the resolution of inflammation (catabasis) in COPD.

Authors:  Aina Noguera; Cristina Gomez; Rosa Faner; Borja Cosio; Ana González-Périz; Joan Clària; Angel Carvajal; Alvar Agustí
Journal:  Respir Res       Date:  2012-11-13

Review 4.  Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants.

Authors:  Kunihiko Hiraiwa; Stephan F van Eeden
Journal:  Mediators Inflamm       Date:  2013-08-22       Impact factor: 4.711

5.  Ventilation impairment of residents around a cement plant.

Authors:  Sul Ha Kim; Chul Gab Lee; Han Soo Song; Hyun Seung Lee; Min Soo Jung; Jae Yoon Kim; Choong Hee Park; Seung Chul Ahn; Seung Do Yu
Journal:  Ann Occup Environ Med       Date:  2015-01-24

6.  Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary disease: a cross-sectional study.

Authors:  Monika Nitschke; Sarah L Appleton; Qiaoyu Li; Graeme R Tucker; Pushan Shah; Peng Bi; Dino L Pisaniello; Robert J Adams
Journal:  Respir Res       Date:  2016-10-24

7.  Identification of differentially expressed genes and signaling pathways in chronic obstructive pulmonary disease via bioinformatic analysis.

Authors:  Xinwei Huang; Yunwei Li; Xiaoran Guo; Zongxin Zhu; Xiangyang Kong; Fubing Yu; Qiang Wang
Journal:  FEBS Open Bio       Date:  2019-09-29       Impact factor: 2.693

8.  Integrated analysis reveals lung fibrinogen gamma chain as a biomarker for chronic obstructive pulmonary disease.

Authors:  Hai Zhang; Chenfei Li; Xiaomin Song; Lei Cheng; Qi Liu; Na Zhang; Liangyu Wei; Kianfan Chung; Ian M Adcock; Chunhua Ling; Feng Li
Journal:  Ann Transl Med       Date:  2021-12

Review 9.  Fine particulate matter in acute exacerbation of COPD.

Authors:  Lei Ni; Chia-Chen Chuang; Li Zuo
Journal:  Front Physiol       Date:  2015-10-23       Impact factor: 4.566

10.  Hydrogen Sulfide Attenuates Particulate Matter-Induced Emphysema and Airway Inflammation Through Nrf2-Dependent Manner.

Authors:  Guohua Jia; Siwang Yu; Wanlu Sun; Jin Yang; Ying Wang; Yongfen Qi; Yahong Chen
Journal:  Front Pharmacol       Date:  2020-02-07       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.